best mid and large cap stock q1 2018

Acm Research (ACMR) had the highest return in Q1 2018 by a US stock with a market cap of $2B+, returning 134.3%.

ASSETQUARTER% RETURN
Acm Research (ACMR)
Q1 2018
134.29%
Arrowhead Pharmaceuticals (ARWR)
Q1 2018
95.39%
Enphase Energy (ENPH)
Q1 2018
91.21%
Crispr Therapeutics (CRSP)
Q1 2018
90.46%
Spyre Therapeutics (SYRE)
Q1 2018
82.35%
Virtu Financial (VIRT)
Q1 2018
81.81%
Nektar Therapeutics (NKTR)
Q1 2018
78.38%
Xenon Pharmaceuticals (XENE)
Q1 2018
75%
Skyline (SKY)
Q1 2018
72.28%
TG Therapeutics (TGTX)
Q1 2018
71.08%
BeiGene (ONC)
Q1 2018
70.18%
Syndax Pharmaceuticals (SNDX)
Q1 2018
62.81%
Ascendis Pharma A-S (ASND)
Q1 2018
62.69%
PTC Therapeutics (PTCT)
Q1 2018
60.5%
Tenet Healthcare (THC)
Q1 2018
59.02%
Twilio (TWLO)
Q1 2018
58.23%
CleanSpark (CLSK)
Q1 2018
57%
Okta (OKTA)
Q1 2018
55.97%
Perpetua Resources (PPTA)
Q1 2018
53.01%
Suzano Papel e Celulose SA ADR (SUZ)
Q1 2018
52.1%
Sunrun (RUN)
Q1 2018
51.87%
Netflix (NFLX)
Q1 2018
50.61%
Axon Enterprise (AXON)
Q1 2018
48.23%
MongoDB (MDB)
Q1 2018
45.01%
Enova International (ENVA)
Q1 2018
43.65%